Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in "wet" age-related macular degeneration and diabetic eye disease.
Scientists have developed a new therapy designed to repair cardiac damage after a heart attack. The study, led by researchers at Columbia University and published in the journal Nature Biomedical ...
In people with mild to moderate hypertension taken off antihypertensive treatment, quarterly and biannual injections of novel RNA silencer zilebesiran showed promise for safely reducing systolic blood ...
Zilebesiran, an interfering RNA, administered every 3-6 months lowers blood pressure in patients with mild to moderate hypertension. For patients with mild to moderate hypertension, a single injection ...
Overall survival (OS) and pathologic response rate from a phase II clinical trial of neoadjuvant GVAX pancreas vaccine (with cyclophosphamide) in combination with nivolumab and stereotactic body ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A single self‑amplifying RNA injection that boosts a heart‑healing peptide cut scarring and ...
For people who have survived a heart attack, the notion of one shot in the arm to help the heart heal, for weeks after, may seem far‑fetched. But thanks to a team of researchers, including a Texas A&M ...
In this Peek Behind the Paper, we learn more about a recently published paper by Joaquin Abugattas-Nuñez Del Prado (Leiden University, The Netherlands; Universidad Peruana Cayetano Heredia, Lima, Perú ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results